Dante Labs·Feb 2, 2023How Dante Labs Is Using Technology to Scale Genomic Testing Capabilities — London PostDante Labs, under co-founder Andrea Riposati, leverages tech to scale genomic testing capabilities.
Andrea Riposati·Feb 2, 2023How Dante Labs Is Using Technology to Scale Genomic Testing Capabilities — London PostDante Labs, under co-founder Andrea Riposati, leverages tech to scale genomic testing capabilities.
Dante Labs·Feb 2, 2023How Dante Labs Makes Genomic Testing Available to People EverywhereWhen Italian entrepreneur Andrea Riposati identified a gap in the market for accessible genomic testing services, he co-founded Dante Labs.
Andrea Riposati·Feb 2, 2023How Dante Labs Makes Genomic Testing Available to People EverywhereWhen Italian entrepreneur Andrea Riposati identified a gap in the market for accessible genomic testing services he co-founded Dante Labs.
Andrea Riposati·Feb 2, 2023How Dante Labs Empowers Consumers With Personalised Genomic TestingDante Labs, under Co-Founder Andrea Riposati, empowers consumers through personalised genomic testing.
Dante Labs·Feb 2, 2023How Dante Labs Empowers Consumers With Personalised Genomic TestingDante Labs, under co-founder Andrea Riposati, empowers customers with personalized genomic testing.
Andrea Riposati·Jan 13, 2023Dante Labs’ CEO Andrea Riposati Is Inspired to Bring Whole Genome Sequencing to Patients WorldwideDante Labs’ CEO Andrea Riposati brings whole genome sequencing worldwide, increasing accessibility to the important procedure.
Dante Labs·Jan 13, 2023Dante Labs’ CEO Andrea Riposati Is Inspired to Bring Whole Genome Sequencing to Patients WorldwideDante Labs and CEO Andrea Riposati work to increase accessibility to whole genome sequencing on a global scale.
Andrea Riposati·Dec 21, 2022How Andrea Riposati Grew Dante Labs’ Annual Revenue to $100 Million By Making Genomics Testing…As the CEO of Dante Labs, Andrea Riposati has broadened global access to direct-to-consumer genome sequencing, reshaping the landscape.
Dante Labs·Dec 21, 2022How Andrea Riposati Grew Dante Labs’ Annual Revenue to $100 Million By Making Genomics Testing…As the CEO of Dante Labs, Andrea Riposati has broadened global access to direct-to-consumer genome sequencing, reshaping the landscape.
